ATE105553T1 - Trisubstituierte triazine und pyrimidine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen. - Google Patents
Trisubstituierte triazine und pyrimidine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.Info
- Publication number
- ATE105553T1 ATE105553T1 AT9292400578T AT92400578T ATE105553T1 AT E105553 T1 ATE105553 T1 AT E105553T1 AT 9292400578 T AT9292400578 T AT 9292400578T AT 92400578 T AT92400578 T AT 92400578T AT E105553 T1 ATE105553 T1 AT E105553T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrimidines
- preparation
- pharmaceutical compositions
- compositions containing
- trisubstituted triazines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
- C07D251/70—Other substituted melamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9102710A FR2673627B1 (fr) | 1991-03-07 | 1991-03-07 | Triazines et pyrimidines trisubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE105553T1 true ATE105553T1 (de) | 1994-05-15 |
Family
ID=9410429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT9292400578T ATE105553T1 (de) | 1991-03-07 | 1992-03-06 | Trisubstituierte triazine und pyrimidine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen. |
Country Status (13)
Country | Link |
---|---|
US (1) | US5238936A (de) |
EP (1) | EP0502788B1 (de) |
JP (1) | JPH0776216B2 (de) |
AT (1) | ATE105553T1 (de) |
AU (1) | AU643880B2 (de) |
CA (1) | CA2062378A1 (de) |
DE (1) | DE69200129T2 (de) |
DK (1) | DK0502788T3 (de) |
ES (1) | ES2056692T3 (de) |
FR (1) | FR2673627B1 (de) |
IE (1) | IE66187B1 (de) |
NZ (1) | NZ241867A (de) |
ZA (1) | ZA921702B (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2664594B1 (fr) * | 1990-07-11 | 1992-09-18 | Adir | Polymethylene-imines disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
US5536722A (en) * | 1991-11-12 | 1996-07-16 | Pfizer Inc. | Triazine derivatives for enhancing antitumor activity |
US5387685A (en) * | 1993-07-16 | 1995-02-07 | American Cyanamid Co | MDR reversal agents |
AU3633997A (en) * | 1996-07-29 | 1998-02-20 | Banyu Pharmaceutical Co., Ltd. | Chemokine receptor antagonists |
US6403308B1 (en) * | 1997-04-30 | 2002-06-11 | Mcgill University | Methods for detecting and reversing resistance to macrocyclic lactone compounds |
EP1832655A3 (de) * | 1997-04-30 | 2008-06-18 | McGILL UNIVERSITY | Verfahren zum Erkennen und Rückgängigmachen von Resistenz gegen makrocyclische Laktonverbindungen |
US6989379B1 (en) | 1999-04-22 | 2006-01-24 | H. Lundbick A/S | Selective NPY (Y5) antagonists |
US6340683B1 (en) | 1999-04-22 | 2002-01-22 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (triazines) |
US6218408B1 (en) | 1999-06-30 | 2001-04-17 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
JP2002543067A (ja) * | 1999-04-22 | 2002-12-17 | シナプティック・ファーマスーティカル・コーポレーション | 選択的なnpy(y5)のアンタゴニスト |
US7273880B2 (en) * | 1999-06-30 | 2007-09-25 | H. Lunbeck A/S | Selective NPY (Y5) antagonists |
US6214853B1 (en) | 1999-06-30 | 2001-04-10 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (bicyclics) |
US6222040B1 (en) | 1999-06-30 | 2001-04-24 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
US6225330B1 (en) | 1999-06-30 | 2001-05-01 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (tricyclics) |
MXPA03001420A (es) | 2000-08-14 | 2004-01-26 | Johnson & Johnson | Pirazoles sustituidos. |
US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
US6376514B1 (en) * | 2000-10-17 | 2002-04-23 | The Procter & Gamble Co. | Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof |
US7223759B2 (en) * | 2003-09-15 | 2007-05-29 | Anadys Pharmaceuticals, Inc. | Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds |
JP6557674B2 (ja) * | 2014-03-12 | 2019-08-07 | ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク | 新規クラスのミュー−オピオイド受容体アゴニスト |
CN107849443B (zh) * | 2015-07-30 | 2020-04-21 | 四川知本快车创新科技研究院有限公司 | 给体和受体之间具有两个非共轭桥的有效热激活延迟荧光有机分子及其在光电器件中的应用 |
WO2017049158A1 (en) | 2015-09-16 | 2017-03-23 | The Trustees Of Columbia University In The City Of New York | Carboxylic diarylthiazepineamines as mu-opioid receptor agonists |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2524467A1 (fr) * | 1982-03-30 | 1983-10-07 | Adir | Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant |
FR2525597B1 (fr) * | 1982-04-21 | 1985-06-07 | Adir | Polymethylene diamines n,n'-substituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant |
FR2544315B1 (fr) * | 1983-04-12 | 1985-07-05 | Adir | Polymethylene imines disubstituees, leurs procedes de preparation, et les compositions pharmaceutiques les renfermant |
CA2004211A1 (en) * | 1988-11-30 | 1990-05-31 | Masataka Syoji | Piperidine derivatives and hyportensives containing the same |
FR2664594B1 (fr) * | 1990-07-11 | 1992-09-18 | Adir | Polymethylene-imines disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
-
1991
- 1991-03-07 FR FR9102710A patent/FR2673627B1/fr not_active Expired - Fee Related
-
1992
- 1992-03-06 US US07/847,916 patent/US5238936A/en not_active Expired - Fee Related
- 1992-03-06 AU AU11468/92A patent/AU643880B2/en not_active Ceased
- 1992-03-06 ZA ZA921702A patent/ZA921702B/xx unknown
- 1992-03-06 JP JP4098998A patent/JPH0776216B2/ja not_active Expired - Fee Related
- 1992-03-06 AT AT9292400578T patent/ATE105553T1/de not_active IP Right Cessation
- 1992-03-06 NZ NZ241867A patent/NZ241867A/en unknown
- 1992-03-06 ES ES92400578T patent/ES2056692T3/es not_active Expired - Lifetime
- 1992-03-06 EP EP92400578A patent/EP0502788B1/de not_active Expired - Lifetime
- 1992-03-06 DE DE69200129T patent/DE69200129T2/de not_active Expired - Fee Related
- 1992-03-06 CA CA002062378A patent/CA2062378A1/fr not_active Abandoned
- 1992-03-06 IE IE920717A patent/IE66187B1/en not_active IP Right Cessation
- 1992-03-06 DK DK92400578.8T patent/DK0502788T3/da active
Also Published As
Publication number | Publication date |
---|---|
US5238936A (en) | 1993-08-24 |
NZ241867A (en) | 1993-02-25 |
ZA921702B (en) | 1992-11-25 |
AU643880B2 (en) | 1993-11-25 |
EP0502788B1 (de) | 1994-05-11 |
FR2673627B1 (fr) | 1993-05-07 |
DK0502788T3 (da) | 1994-09-12 |
EP0502788A1 (de) | 1992-09-09 |
AU1146892A (en) | 1992-09-10 |
ES2056692T3 (es) | 1994-10-01 |
JPH05125062A (ja) | 1993-05-21 |
CA2062378A1 (fr) | 1992-09-08 |
JPH0776216B2 (ja) | 1995-08-16 |
DE69200129T2 (de) | 1994-12-01 |
DE69200129D1 (de) | 1994-06-16 |
FR2673627A1 (fr) | 1992-09-11 |
IE920717A1 (en) | 1992-09-09 |
IE66187B1 (en) | 1995-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE105553T1 (de) | Trisubstituierte triazine und pyrimidine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
ATE114316T1 (de) | Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel. | |
ATE104279T1 (de) | 4-fluorbenzolderivate, herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen. | |
DE69202313D1 (de) | Naphthylethylharnstoff und Naphthylethylthioharnstoff Verbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten. | |
DE69111582D1 (de) | 1,4-Disubstituierte Piperazine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen. | |
ATE10368T1 (de) | Uracilderivate, verfahren zu ihrer herstellung und eine diese enthaltende pharmazeutische zubereitung. | |
ES2118203T3 (es) | Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
DE69302829D1 (de) | Bicyclische pyrimidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate | |
DE69406853T2 (de) | Alpha Aminosäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
DE69321861D1 (de) | 3-Aminochroman-Spiroderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
DE69201368D1 (de) | 1-(Alkoxybenzyl)piperazineamide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. | |
PT77309B (de) | Isochinolinderivate verfahren zu ihrer herstellung pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung | |
NZ238909A (en) | Pyrimidine or triazine derivatives, preparation and medicaments thereof | |
DE69422532D1 (de) | 2-[4-(4-Azolylbutyl)-1-piperazinyl]-5-hydroxypyrimidin-Derivate, deren Herstellung und deren Verwendung als Heilmittel | |
IL79253A (en) | Pharmaceutical compositions containing 4-amino-2-(imidazolidin-2-on-1-yl)-5-(3-trifluoromethyl-phenyl-amino-carbonyl)pyrimidines | |
PT82175A (de) | Neue 3-pyridylmethylnaphthylderivate verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE69101097D1 (de) | Verwendung von Triazin- und Pyrimidinderivaten zur Herstellung von Arzneimitteln zur Überwindung der Arzneimittelresistenz gegenüber Antikrebs- und Antimalariamittel. | |
DE69300011D1 (de) | Diacylglycerol-Nicotinate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. | |
DE69110570D1 (de) | Arzneimittel, enthaltend ein N6-substituiertes Adenosin-Derivat zur Behandlung von Hyperlipidämie oder Hypertriglyceridämie. | |
DE69400283D1 (de) | (Cyclohexyl)alkenderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
DE69211773D1 (de) | Amidderivate von 1-Amino-Octahydropyrido[2,1-c][1,4]oxazin, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen | |
ATE5968T1 (de) | 6-substituierte arylpyrido(2,3-d)pyrimidin-7amine, deren derivate und salze, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |